Methods that allow for chemical site-selective dual protein modification are scarce. Here, we provide proof-of-concept for the orthogonality and compatibility of a method for regioselective lysine modification with strategies for protein modification at cysteine and genetically encoded ketone-tagged amino acids. This sequential, orthogonal approach was applied to albumin and a therapeutic antibody to create functional dual site-selectively labelled proteins.
Keywords: Albumin; Antibodies; Bioorthogonal labelling; Lysine modification; Protein modification.
Copyright © 2020 Elsevier Ltd. All rights reserved.